Kidney Transplant Stakeholders’ Perspectives on the Future of Xenotransplantation in Canada

Overview
There are more patients waiting for a kidney transplant than available organs. Xenotransplantation refers to the use of non-human animal organs for transplantation into humans. The last few years have seen rapid advances in the development of genetically modified pigs and the experimental transplantation of pig kidneys into humans. Xenotransplantation could provide a solution to the shortage of organs for transplantation, but it raises major ethical and social questions.
This study aims to collect perspectives on the future of xenotransplantation in Canada from those involved in kidney transplantation as patients, donors, family members, or professionals. The study is led by researchers at the University of Montreal Hospital Centre (CHUM), the McGill University Health Centre (MUHC) and the University of British Columbia (UBC). Qualitative interviews or focus group discussions will cover topics such as expectations, ethical concerns, acceptability, and recommendations regarding xenotransplantation. Study results will lead to policy recommendations and will be presented to transplant professionals.
This project has been approved by the CHUM ethics committee (IRB). The project number is MP-02-2026-13121.
Participant commitment:
Participation in this study involves a one-time interview, preceded by a short online sociodemographic survey and a brief recorded presentation of background information. Participants can choose between an individual or collective (focus group) interview.
Individual interviews will last 40-60 minutes and can be done over the phone or video link at a time that suits the participant.
Eligibility
Eligible participants are adult (18+) kidney transplant recipients, kidney transplant candidates, living kidney donors, and family caregivers. We are also recruiting professionals involved in kidney transplantation, organ procurement, and the ethics of research involving animals.


